GlassScriptPhysician profile
Stephen Armond Mayer
NPI 1982678975
$18,081.53
in general payments reported to CMS, 2019-2025
47 companies · $5,559 in 2025
The $5,559 reported for 2025 was more than what 83% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2022: $1,238 · 2023: $11K · 2024: $533 · 2025: $5,559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,116 · Honoraria: $1,975 · Travel and Lodging: $1,113 · Education: $23.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,510.00 |
| Food and Beverage | $3,116.02 |
| Honoraria | $1,975.00 |
| Travel and Lodging | $1,112.94 |
| Education | $23.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $7,697.52 | 2023-2024 | Orgovyx |
| Exelixis INC. | $3,338.97 | 2024-2025 | Cabometyx |
| Ipsen Biopharmaceuticals, INC | $2,876.98 | 2023-2024 | Tazverik, Onivyde |
| Myovant Sciences INC. | $1,238.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $568.68 | 2023-2025 | Lynparza, Imfinzi, Enhertu |
| Merck Sharp & Dohme LLC | $274.31 | 2024-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $203.89 | 2024-2025 | Balversa, Erleada, Akeega |
| Novartis Pharmaceuticals Corporation | $192.16 | 2024-2025 | |
| Lilly USA, LLC | $97.82 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Glaxosmithkline, LLC. | $95.12 | 2024-2025 | Ojjaara, Jemperli |
| Pfizer INC. | $84.56 | 2025 | |
| Astellas Pharma US INC | $76.46 | 2024-2025 | Xtandi, Vyloy |
| Celgene Corporation | $71.81 | 2019-2025 | Reblozyl |
| Tempus Ai, INC | $71.29 | 2025 | Xt Cdx |
| Geron Corporation | $71.16 | 2025 | Rytelo |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $67.57 | 2024-2025 | |
| Rigel Pharmaceuticals, INC. | $65.39 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Genmab U.S., INC. | $60.55 | 2025 | Tivdak |
| Iovance Biotherapeutics, INC. | $60.36 | 2025 | Amtagvi |
| Beigene USA, INC. | $59.99 | 2024-2025 | Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $59.72 | 2025 | Alunbrig, Fruzaqla |
| Gilead Sciences, INC. | $54.97 | 2024-2025 | Trodelvy |
| Pharmaessentia USA Corporation | $44.04 | 2025 | Besremi |
| Abbvie INC. | $43.87 | 2025 | |
| Incyte Corporation | $41.72 | 2024-2025 | Jakafi, Zynyz, Monjuvi |
| Jazz Pharmaceuticals INC. | $39.89 | 2025 | |
| Aveo Pharmaceuticals, INC. | $39.71 | 2025 | |
| Beone Medicines USA, INC. | $39.26 | 2025 | Brukinsa, Tevimbra |
| Kite Pharma, INC. | $37.90 | 2025 | Yescarta |
| Stemline Therapeutics INC. | $35.49 | 2024-2025 | Orserdu |
| Regeneron Healthcare Solutions, INC. | $29.91 | 2025 | Libtayo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.50 | 2024 | |
| Pharmacosmos Therapeutics INC. | $24.28 | 2024 | Cosela |
| Sirtex Medical INC | $24.10 | 2024 | Sir-Spheres Microspheres |
| Amneal Pharmaceuticals LLC | $24.09 | 2025 | Pemrydi Rtu |
| Coherus Oncology, INC. | $23.85 | 2025 | Loqtorzi |
| Invivyd INC | $23.85 | 2025 | Pemgarda |
| Spectrum Pharmaceuticals INC. | $23.43 | 2025 | Rolvedon |
| Caris Mpi, INC. | $22.65 | 2025 | Mi Cancer Seek |
| Acrotech Biopharma INC. | $21.63 | 2025 | Beleodaq |
| Clovis Oncology, INC. | $20.36 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.86 | 2019 | |
| Daiichi Sankyo INC. | $19.56 | 2025 | Datroway |
| Eisai INC. | $19.23 | 2025 | |
| Teleflex LLC | $18.24 | 2025 | Barrigel |
| Emd Serono, INC. | $16.28 | 2025 | |
| Verastem, INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Mayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.